MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6506-1427-1439$20.00
Mol Pharmacol 65:1427-1439, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo, R. K. H.
Right arrow Articles by Wong, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, R. K. H.
Right arrow Articles by Wong, Y. H.

Signal Transducer and Activator of Transcription 3 Activation by the {delta}-Opioid Receptor via G{alpha}14 Involves Multiple Intermediates

Rico K. H. Lo, and Yung H. Wong

Department of Biochemistry, Molecular Neuroscience Center, and Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China

The hematopoietic-specific G{alpha}14 links a variety of G protein-coupled receptors to phospholipase C{beta} (PLC{beta}) stimulation. Recent studies reveal that several G{alpha} subunits are capable of activating signal transducer and activator of transcription (STAT) proteins. In the present study, we investigated the mechanism by which G{alpha}14 mediates receptor-induced stimulation of STAT3. In human embryonic kidney 293 cells, coexpression of G{alpha}14 with {delta}-opioid receptor supported [D-Pen2, D-Pen5]enkephalin (DPDPE)-induced STAT3 phosphorylations at both Tyr705 and Ser727 in a pertussis toxin-insensitive manner. The constitutively active G{alpha}14QL mutant also induced STAT3 phosphorylations at these sites and promoted STAT3-dependent luciferase activity. Requirements for PLC{beta}, protein kinase C (PKC), and calmodulin-dependent kinase II (CaMKII) in G{alpha}14QL-induced STAT3 activation were demonstrated by their respective inhibitors as well as by coexpression of their dominant-negative mutants. Inhibition of c-Src and Janus kinase 2 and 3 activities abolished STAT3 activation induced by G{alpha}14QL, but no physical association between G{alpha}14QL and c-Src could be detected by coimmunoprecipitation. Various intermediates along the extracellular signal-regulated kinase signaling cascade were apparently required for G{alpha}14QL-induced STAT3 activation; they included Ras/Rac1, Raf-1, and mitogen-activated protein kinase kinase-1/2. In contrast, functional blockade of c-Jun N-terminal kinase, p38 mitogen-activated protein kinase, and phosphatidylinositol-3 kinase had no effect on G{alpha}14QL-induced responses. PLC{beta}, PKC, and CaMKII were shown to be involved in G{alpha}14QL-mediated c-Src phosphorylation. Similar results were obtained with human erythro-leukemia cells upon DPDPE treatment. These results demonstrate for the first time that G{alpha}14 activation can lead to STAT3 stimulation via a complex signaling network involving multiple intermediates.


Received November 3, 2003; accepted February 26, 2004

Address correspondence to: Dr. Yung H. Wong, Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China. E-mail: boyung{at}ust.hk




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. L. Weber, M. Farooqui, J. Nguyen, M. Ansonoff, J. E. Pintar, R. P. Hebbel, and K. Gupta
Morphine induces mesangial cell proliferation and glomerulopathy via {kappa}-opioid receptors
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1388 - F1397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Houston, H. H. C. Lee, A. M. Hosie, S. J. Moss, and T. G. Smart
Identification of the Sites for CaMK-II-dependent Phosphorylation of GABAA Receptors
J. Biol. Chem., June 15, 2007; 282(24): 17855 - 17865.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. F. Liu, R. K. H. Lo, C. S. S. Wong, C. Morris, H. Wise, and Y. H. Wong
Activation of STAT3 by G{alpha}s Distinctively Requires Protein Kinase A, JNK, and Phosphatidylinositol 3-Kinase
J. Biol. Chem., November 24, 2006; 281(47): 35812 - 35825.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Gross, A. K. Hsu, and G. J. Gross
The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H827 - H834.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Borner, V. Hollt, and J. Kraus
Cannabinoid Receptor Type 2 Agonists Induce Transcription of the {micro}-Opioid Receptor Gene in Jurkat T Cells
Mol. Pharmacol., April 1, 2006; 69(4): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Morou and Z. Georgoussi
Expression of the Third Intracellular Loop of the {delta}-Opioid Receptor Inhibits Signaling by Opioid Receptors and Other G Protein-Coupled Receptors
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1368 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. F. Liu and Y. H. Wong
Activation of Nuclear Factor {kappa}B by Somatostatin Type 2 Receptor in Pancreatic Acinar AR42J Cells Involves G{alpha}14 and Multiple Signaling Components: A MECHANISM REQUIRING PROTEIN KINASE C, CALMODULIN-DEPENDENT KINASE II, ERK, AND c-Src
J. Biol. Chem., October 14, 2005; 280(41): 34617 - 34625.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics